AVIR Green Hills Biotechnology is a clinical stage vaccine company that develops vaccines against influenza, tuberculosis and cervical cancer. The lead product is deltaFLU a novel intranasal influenza vaccine. deltaFLU induces both, local and systemic immune responses and is currently tested in phase II trials.
The World Influenza Congress is a multi-faceted event
|
You may also like to attend:
See more › |
We run training courses on:
See more › |